Aortic Valve Replacement Devices Market Report 2026

Aortic Valve Replacement Devices Market Overview

• Aortic Valve Replacement Devices market size has reached to $8.85 billion in 2025 • Expected to grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 10.4% • Growth Driver: Surge In Valve Replacement Surgeries Fueling The Growth Of The Market Due To Rising Age-Related Heart Valve Disorders • Market Trend: Innovative Design Features Supporting Safer And More Accurate Valve Placement • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Aortic Valve Replacement Devices Market?

Aortic valve replacement devices refer to medical devices designed to replace a damaged or diseased aortic valve to restore normal cardiac function. They enable controlled and efficient blood flow from the heart into the aorta by replicating the function of a natural valve. The devices integrate engineered valve components and implantation technologies to ensure reliable performance and long-term cardiovascular support. The main product types of aortic valve replacement devices include balloon-expandable, self-expandable, mechanically expandable, and aortic regurgitation devices. Balloon-expandable devices refer to valves that are mounted on a balloon catheter and expanded at the target site to replace the diseased aortic valve. These devices are made using leaflet materials such as bovine pericardium and porcine pericardium, and frame materials including cobalt-chromium and nitinol, and are utilized by end users across inpatient facilities and outpatient facilities.

What Is The Aortic Valve Replacement Devices Market Growth Forecast?

The aortic valve replacement devices market size is expected to see rapid growth in the next few years. It will grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing preference for transcatheter procedures, rising investments in structural heart programs, growing demand for outpatient cardiac interventions, expansion of advanced biomaterials usage, increasing procedural success rates. Major trends in the forecast period include increasing adoption of minimally invasive valve replacement, rising use of transcatheter valve technologies, growing demand for self-expandable valves, expansion of patient-specific valve designs, enhanced focus on long-term valve durability.

Global Aortic Valve Replacement Devices Market Segmentation

1) By Product: Balloon-Expandable; Self-Expandable; Mechanically Expandable; Aortic Regurgitation 2) By Leaflet Material: Bovine Pericardium; Porcine Pericardium 3) By Frame Material: Cobalt-Chromium; Nitinol 4) By End-Use: Inpatient Facilities; Outpatient Facilities Subsegments: 1) By Balloon-Expandable: Balloon Pre-Dilation; Balloon Post-Dilation; Balloon Valves 2) By Self-Expandable: Supra-Annular Valves; Intra-Annular Valves; Resheathable Valves 3) By Mechanically Expandable: Mechanically Adjustable Valves; Radial Force Valves; Repositionable Valves 4) By Aortic Regurgitation: Surgical Valve Replacement; Transcatheter Valve Replacement; Repair Devices

What Is The Driver Of The Aortic Valve Replacement Devices Market?

The rising number of valve replacement surgeries is expected to propel the growth of the aortic valve replacement devices market going forward. Valve replacement surgeries refer to medical procedures performed to repair or replace damaged heart valves in order to restore normal blood flow and improve cardiac function. The rise in valve replacement surgeries due to the increasing of age-related heart valve disorders is leading to higher demand for surgical interventions to manage deteriorating valve function and prevent complications. Aortic valve replacement devices support valve replacement surgeries by enabling safer, more effective valve repair or replacement, improving procedural outcomes, and supporting increased surgical adoption. For instance, in June 2025, according to the British Heart Foundation, the UK-based cardiovascular research charity, over 13,034 aortic valve replacement (AVR) and nearly 7,695 transcatheter aortic valve implantation (TAVI) procedures were performed in the United Kingdom in 2022/23, with TAVI procedures increasing, reflecting growing adoption of less invasive valve replacement. Therefore, the rising number of valve replacement surgeries is driving the growth of the aortic valve replacement devices industry.

Key Players In The Global Aortic Valve Replacement Devices Market

Major companies operating in the aortic valve replacement devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Bracco SpA, Biotronik SE & Co. KG, LivaNova Plc, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Artivion Inc., LifeTech Scientific Corporation, TTK Healthcare Limited, Braile Biomedica, Venus Medtech Inc., SMT Pvt Ltd, JenaValve Technology Inc., Peijia Medical Limited, CryoLife Inc., CorLife, and Colibri Heart Valve LLC.

Global Aortic Valve Replacement Devices Market Trends and Insights

Major companies operating in the aortic valve replacement devices market are focusing on advanced innovations, such as three radiopaque vision markers to enhance procedural visibility, improve deployment accuracy, and enable precise valve positioning during transcatheter implantation procedures. Three radiopaque vision markers are clearly visible reference points integrated into a medical device that enhance fluoroscopic visibility, helping clinicians accurately position and deploy the device during minimally invasive procedures. For instance, in January 2025, Abbott Laboratories, the US-based healthcare company, launched Navitor Vision in India, the latest version of its transcatheter aortic valve implantation/replacement (TAVI/TAVR) system. The device is designed to treat patients with symptomatic severe aortic stenosis who are at high or extreme surgical risk. Navitor Vision features three radiopaque vision markers for enhanced visibility during implantation, a dynamic sealing cuff to reduce blood leakage, and is delivered using Abbott’s FlexNav delivery system for precise, minimally invasive valve placement. It provides a less invasive alternative to surgical aortic valve replacement, improving outcomes and accessibility for high-risk patients.

What Are Latest Mergers And Acquisitions In The Aortic Valve Replacement Devices Market?

In August 2024, Edwards Lifesciences Corporation, a US-based technology company, acquired JC Medical for an undisclosed amount. Through this acquisition, Edwards Lifesciences aims to expand its transcatheter aortic valve replacement (TAVR) portfolio by integrating JC Medical’s J Valve System, enhancing treatment options for severe aortic regurgitation, and strengthening its global leadership in structural heart therapies. JC Medical Inc. is a US-based company specialized in developing transcatheter aortic valve replacement devices, including the J Valve System, and advancing innovative solutions for treating severe aortic regurgitation and other structural heart conditions.

Regional Insights

North America was the largest region in the aortic valve replacement devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Aortic Valve Replacement Devices Market?

The aortic valve replacement devices consists of sales of surgical aortic valves, transcatheter aortic valve replacement (TAVR) systems, balloon-expandable valves, self-expandable valves, sutureless valves, and related implantation accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and medical facilities) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Aortic Valve Replacement Devices Market Report 2026?

The aortic valve replacement devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aortic valve replacement devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.